 | ||||||||||||
|
| Vitamin D deficiency linked to portal hypertension complications, poor ... Patients with alcoholic cirrhosis and severe vitamin D deficiency are at a greater risk for death and more likely to have severe cirrhosis and experience portal hypertension-related complications, according to data presented at the International Liver ... Healio - Fri, 03 May 2013 06:49 | |
| New rationale for treating patients with cirrhosis and portal hypertension New data from clinical studies presented for the first time at the International Liver Congress- 2013 provide new rationale for an old and established treatment option for portal hypertension. Additionally, spleen stiffness predicts the occurrence of ... News-Medical.net - Fri, 26 Apr 2013 07:06 | |
 | Stiff Spleen Predicts Decompensation in Cirrhotic Patients - Medscape "In compensated hepatitis C–related cirrhotic patients, the proposed model…could replace hepatic venous pressure gradient for predicting portal-hypertension-related clinical decompensation," senior author Davide Festi, MD, from the University of ... Medscape - Fri, 26 Apr 2013 14:05 |
| Shares of Galectin Therapeutics (GALT +20%) are on a tear today after the ... ... +20%) are on a tear today after the company released pre-clinical test results of the drugs GR-MD-02 and GM-CT-01, which were found to reverse the most advanced stage of liver cirrhosis, as well as reduction in portal hypertension in animal ... Seeking Alpha - Mon, 29 Apr 2013 09:27 | |
| Galectin (GALT) Issues Encouraging Update on anti-Galectin Drugs on Liver ... StreetInsider.com (subscription) - Mon, 29 Apr 2013 05:17 | |
| Galectin Therapeutics, Inc. (NASDAQ: GALT) Spikes on Positive Data from ... OTCEquity.com - Mon, 29 Apr 2013 12:38 | |
| Beta-blockers reduced bacterial translocation, improved intestinal ... Severe portal hypertension, defined as hepatic venous pressure gradient (HPVG) of 20 mmHg or greater, was observed in 35 cases. These patients had significantly higher urine sucrose levels (P=.049), sucrose/mannitol ratios (P=.007) and intestinal ... Healio - Wed, 01 May 2013 11:57 | |
| Notable Movers - Hypertension Diagnostics, Inc. (OTCMKTS:HDII), Force Energy ... Hypertension Diagnostics, Inc. engages in plastics reprocessing business in the United States. The company primarily processes high-density polyethylene, postconsumer bottles, and low-density polyethylene films into reprocessed pellets. It also ... Techsonian (press release) - Fri, 17 May 2013 08:49 | |
| Intercept Pharmaceuticals: The Risks That No One Is Talking About Additionally, we point out that Intercept's POISE trial has excluded some of the sickest and most refractory PBC patients, those with portal hypertension and cirrhosis, narrowing the patient population in the study and leaving the question of just how ... Seeking Alpha - Fri, 19 Apr 2013 06:38 | |
| A new state campaign aims to register more organ donors - Reading Eagle When the 28-year-old Birdsboro resident recounts his health struggles, he spends 20 minutes describing his portal hypertension, the hole in his small intestine, the liver transplant of 2006, the medically induced coma of 2011, blood infections. The ... Reading Eagle - Mon, 06 May 2013 21:07 | |